ClinicalTrials.gg
RecruitingNCT00341744Updated Jul 31, 2026

Providing Access to the Visual Environment

An observational study in Vision Impairment, sponsored by Vanderbilt University. Recruiting at 1 site in United States. Open to participants aged 3 Years to 21 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-31.

Sponsored by Vanderbilt University · Observational

From the registry’s dates

  • Started Jul 2001; still recruiting 25 years 4 months later.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
795
Ages
3 Years to 21 Years
Sex
All
01

Study summary

Providing Access to the Visual Environment is a pediatric low vision grant which has the ability to provide comprehensive, interdisciplinary low vision rehabilitation services to every child in Tennessee with a vision impairment. Children, ages 3-21, with best-corrected vision of 20/50 or worse in the better seeing eye are prescribed optical devices to improve their visual functioning and trained to use the devices.

Read the detailed description

Subjects are enrolled each school year based on referrals from school systems in Tennessee, ophthalmologists, and optometrists. A total of 90 new students are enrolled each year. Students are provided a comprehensive low vision rehabilitation evaluation by a low vision optometrist and prescribed optical devices to improve distance appreciation, near reading, and other tasks based on individual needs. Students are then trained to use the devices efficiently by master's level teachers of the visually impaired. The teachers travel to the students environment (school/home/work) for the training.

Variables such as ocular disease, age, visual acuity, visual improvement with optical devices, type of optical device, and reading speed are defined for each student. Providing Access to the Visual Environment also provides...

02

Conditions studied

  • Vision Impairment

Keywords

  • Vision
  • Aids
03

In context

Vision Disorders

360 studies on the registry are indexed under Vision Disorders; 84 are open to participants now.

This study's planned enrollment of 795 is above the median of 126 across 97 observational studies indexed under Vision Disorders.

Browse Vision Disorders studies →

Lead sponsor

Vanderbilt University is the lead sponsor of 522 studies on the registry; 20 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 5 (63%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Children age 3 to 21 years of age, enrolled in a TN school, with visual impairment

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Children age 3 to 21 years of age Enrollment in a school in Tennessee (private or public)

- Children that are eligible for services due to visual impairment Low vision

Exclusion criteria

Exclusion Criteria:

  • Children who do not have the potential to become readers or use their vision for reading
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
795 participants (estimated)
06

What researchers measure

Primary outcomes

  1. Success to utilize optical devices

    Training with external optical devices to improve visual outcome

    Time frame: 3-4 months

07

Study locations

1 of 1 sites recruiting
  • Saige Wilkins
    Nashville, Tennessee 37232, United States
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00341744
Collaborators
Tennessee Department of Education
Responsible party
Lori Ann Kehler (Associate Professor of Ophthalmology, Vanderbilt University) — Principal investigator
First posted
Jun 21, 2006
Start date
Jul 2001
Primary completion
Dec 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Jul 31, 2026

Study contacts

Lori Ann F Kehler, O.D.
Contact
lori.ann.kehler@Vanderbilt.Edu
615-936-2020
Saige Wilkins, CTS
Contact
saige.wilkins@vumc.org
615-936-1474
Lori Ann Kehler, O.D.
principal investigator · Vanderbilt Eye Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion